Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Cause of death in follicular lymphoma in the first decade of the rituximab era: a pooled analysis of French and US cohorts
Purpose Although the life expectancy of patients with follicular lymphoma (FL) has
increased, little is known of their causes of death (CODs) in the rituximab era. Patients and …
increased, little is known of their causes of death (CODs) in the rituximab era. Patients and …
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL …
M Khouja, L Jiang, K Pal, PJ Stewart, B Regmi… - Leukemia, 2024 - nature.com
Recent studies highlighted genetic aberrations associated with prognosis in Mantle Cell
lymphoma (MCL), yet comprehensive testing is not implemented in clinical routine. We …
lymphoma (MCL), yet comprehensive testing is not implemented in clinical routine. We …
The simplified follicular lymphoma PRIMA‐prognostic index is useful in patients with first‐line chemo‐free rituximab‐based therapy
E Kimby, S Lockmer, H Holte… - British Journal of …, 2020 - Wiley Online Library
Follicular lymphoma (FL) is a heterogeneous disease; therefore, reliable prognostic tools
are needed to plan treatment strategies. The FL International Prognostic Index (FLIPI) was …
are needed to plan treatment strategies. The FL International Prognostic Index (FLIPI) was …
Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy
JJ Rodríguez-Sevilla, C Fernández-Rodríguez… - Blood …, 2023 - ashpublications.org
Several clinical risk models have been proposed to predict the outcome of follicular
lymphoma (FL). The development of next-generation sequencing technologies has allowed …
lymphoma (FL). The development of next-generation sequencing technologies has allowed …
Impact of age on clinical risk scores in follicular lymphoma
Abstract The Follicular Lymphoma (FL) International Prognostic Index (FLIPI) and FLIPI-2
are well-described clinical risk models. Age> 60 years at diagnosis is a risk factor in both …
are well-described clinical risk models. Age> 60 years at diagnosis is a risk factor in both …
Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials
Limited data exist to describe the clinical features and outcomes for elderly patients with
follicular lymphoma (FL). The Follicular Lymphoma Analysis of Surrogacy Hypothesis …
follicular lymphoma (FL). The Follicular Lymphoma Analysis of Surrogacy Hypothesis …
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models
S Alig, V Jurinovic, M Shahrokh Esfahani… - Blood …, 2020 - ashpublications.org
High-dose therapy and autologous stem cell transplantation (HDT/ASCT) is an effective
salvage treatment for eligible patients with follicular lymphoma (FL) and early progression of …
salvage treatment for eligible patients with follicular lymphoma (FL) and early progression of …
Long‐term survival and prognostic analysis of advanced stage follicular lymphoma in the rituximab era: A China single‐center retrospective study
Y Zhou, Y Qin, X He, P Liu, J Yang… - Asia‐Pacific Journal …, 2021 - Wiley Online Library
Aim The prognosis and treatment options for follicular lymphoma (FL) remain heterogenous.
This study aimed to analyze the prognostic impact of rituximab maintenance and evaluate …
This study aimed to analyze the prognostic impact of rituximab maintenance and evaluate …
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma
Frailty and concurrent medical conditions are crucial factors in the management of follicular
lymphoma (FL). We evaluated the impact of age and comorbidity on survival, causes of …
lymphoma (FL). We evaluated the impact of age and comorbidity on survival, causes of …
Precision medicine in follicular lymphoma: Focus on predictive biomarkers
M Sorigue, E Cañamero, JM Sancho - Hematological Oncology, 2020 - Wiley Online Library
Current care for patients with follicular lymphoma (FL) offers most of them long‐term survival.
Improving it further will require careful patient selection. This review focuses on predictive …
Improving it further will require careful patient selection. This review focuses on predictive …